Oregon Public Employees Retirement Fund’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.4M Buy
70,799
+4,384
+7% +$367K 0.07% 227
2026
Q1
$5.32M Hold
66,415
0.07% 223
2025
Q4
$5.66M Sell
66,415
-700
-1% -$57.4K 0.07% 208
2025
Q3
$5.22M Buy
67,115
+16,429
+32% +$1.28M 0.07% 223
2025
Q2
$3.96M Hold
50,686
0.07% 211
2025
Q1
$3.67M Buy
50,686
+130
+0.3% +$9.3K 0.07% 218
2024
Q4
$3.74M Sell
50,556
-947
-2% -$66.3K 0.07% 214
2024
Q3
$3.4M Sell
51,503
-280
-0.5% -$20.3K 0.06% 241
2024
Q2
$4.78M Sell
51,783
-90
-0.2% -$7.97K 0.09% 163
2024
Q1
$4.96M Sell
51,873
-17,071
-25% -$1.43M 0.1% 162
2023
Q4
$5.26M Sell
68,944
-12,971
-16% -$903K 0.09% 195
2023
Q3
$5.68M Sell
81,915
-16,307
-17% -$1.31M 0.08% 245
2023
Q2
$9.27M Sell
98,222
-2,129
-2% -$185K 0.11% 191
2023
Q1
$8.3M Sell
100,351
-4,000
-4% -$314K 0.1% 216
2022
Q4
$7.79M Sell
104,351
-990
-0.9% -$76.3K 0.1% 228
2022
Q3
$8.7M Sell
105,341
-5,451
-5% -$525K 0.12% 181
2022
Q2
$10.5M Sell
110,792
-101,271
-48% -$10.5M 0.16% 123
2022
Q1
$25M Buy
212,063
+12,382
+6% +$1.39M 0.26% 72
2021
Q4
$25.9M Buy
199,681
+73,539
+58% +$8.58M 0.28% 59
2021
Q3
$14.3M Sell
126,142
-5,805
-4% -$663K 0.16% 124
2021
Q2
$13.7M Buy
131,947
+4,450
+3% +$419K 0.15% 132
2021
Q1
$10.7M Buy
127,497
+3,256
+3% +$275K 0.13% 153
2020
Q4
$11.3M Sell
124,241
-5,413
-4% -$449K 0.15% 133
2020
Q3
$10.3M Sell
129,654
-9,729
-7% -$759K 0.15% 135
2020
Q2
$9.63M Sell
139,383
-89,580
-39% -$6.37M 0.14% 143
2020
Q1
$14.4M Sell
228,963
-78,543
-26% -$5.66M 0.25% 85
2019
Q4
$23.9M Buy
307,506
+86,943
+39% +$6.79M 0.33% 63
2019
Q3
$16.2M Buy
220,563
+729
+0.3% +$51.2K 0.21% 102
2019
Q2
$13.5M Buy
219,834
+19,713
+10% +$1.19M 0.18% 113
2019
Q1
$12.8M Sell
200,121
-8,214
-4% -$469K 0.18% 113
2018
Q4
$10.6M Buy
208,335
+59,640
+40% +$3.02M 0.17% 123
2018
Q3
$8.63M Buy
148,695
+1,767
+1% +$86.4K 0.12% 172
2018
Q2
$7.13M Sell
146,928
-13,980
-9% -$653K 0.1% 195
2018
Q1
$7.48M Buy
160,908
+546
+0.3% +$23.7K 0.11% 186
2017
Q4
$6.03M Buy
160,362
+1,794
+1% +$65.8K 0.09% 226
2017
Q3
$5.78M Buy
158,568
+10,479
+7% +$400K 0.09% 223
2017
Q2
$5.84M Hold
148,089
0.1% 211
2017
Q1
$4.64M Buy
148,089
+300
+0.2% +$9.39K 0.09% 230
2016
Q4
$4.62M Sell
147,789
-145,767
-50% -$4.72M 0.1% 219
2016
Q3
$11.8M Buy
293,556
+125,559
+75% +$4.73M 0.25% 83
2016
Q2
$5.58M Buy
167,997
+33,687
+25% +$1.15M 0.12% 165
2016
Q1
$3.95M Buy
134,310
+5,160
+4% +$142K 0.09% 224
2015
Q4
$3.4M Buy
129,150
+4,200
+3% +$109K 0.08% 248
2015
Q3
$2.96M Buy
124,950
+1,200
+1% +$29K 0.07% 277
2015
Q2
$2.94M Sell
123,750
-8,400
-6% -$190K 0.07% 302
2015
Q1
$3.14M Buy
132,150
+3,600
+3% +$80.8K 0.07% 295
2014
Q4
$2.73M Buy
128,550
+36,156
+39% +$726K 0.06% 320
2014
Q3
$1.57M Sell
92,394
-1,200
-1% -$18.9K 0.04% 506
2014
Q2
$1.34M Sell
93,594
-600
-0.6% -$8.13K 0.03% 603
2014
Q1
$1.16M Sell
94,194
-1,800
-2% -$20.8K 0.03% 650
2013
Q4
$1.05M Buy
95,994
+31,200
+48% +$352K 0.03% 667
2013
Q3
$752K Buy
64,794
+288
+0.4% +$3.37K 0.03% 655
2013
Q2
$722K Buy
+64,506
New +$764K 0.03% 646

Other funds holding EW

Oregon Public Employees Retirement Fund's EW Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Edwards Lifesciences (EW) stake by 6.6% in Q2 2026, buying an estimated $367K and bringing the position to 70,799 shares worth $6.4M. The position accounts for 0.07% of the portfolio, ranked #227.

Oregon Public Employees Retirement Fund first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.9M in Q4 2021. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 70,799 shares of Edwards Lifesciences worth $6.4M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 4,384 Edwards Lifesciences shares in Q2 2026, an estimated $367K.
  • Edwards Lifesciences made up 0.07% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #227 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • Oregon Public Employees Retirement Fund's Edwards Lifesciences position peaked at $25.9M in Q4 2021.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.